METASTATIC BLADDER CANCER
Clinical trials for METASTATIC BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pazopanib dose hunt in frail seniors halted early
Disease control TerminatedThis phase 1 study tested the cancer drug pazopanib in 18 frail elderly patients (aged 75+) with metastatic cancers like kidney, lung, or breast cancer. The goal was to find the highest safe dose by starting at 400 mg daily and increasing if tolerated. The study was terminated ea…
Matched conditions: METASTATIC BLADDER CANCER
Phase: PHASE1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Bladder cancer trial halted: could trilaciclib have saved bone marrow?
Disease control TerminatedThis phase 2 trial tested whether adding trilaciclib (Cosela) to standard chemotherapy and avelumab could help people with advanced bladder cancer by protecting their bone marrow. The study enrolled 92 adults with untreated, locally advanced or metastatic urothelial carcinoma. Un…
Matched conditions: METASTATIC BLADDER CANCER
Phase: PHASE2 • Sponsor: G1 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC